4d Molecular Therapeutics, INC. (FDMT) SEC Filings — 2024
32 SEC filings for 4d Molecular Therapeutics, INC. (FDMT) in 2024.
Filings
- 4D Molecular Therapeutics Reports Unregistered Equity Sale — 8-K · Dec 11, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Dec 6, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 15, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- 4D Molecular Therapeutics Q3 Update — 10-Q · Nov 13, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- 4d Molecular Therapeutics, INC. SC 13G Filing — SC 13G · Nov 6, 2024
- 4d Molecular Therapeutics, INC. SC 13G Filing — SC 13G · Nov 4, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 21, 2024
- 4D Molecular Therapeutics Files 8-K Report — 8-K · Sep 18, 2024
- 4D Molecular Therapeutics Q2 2024 Update — 10-Q · Aug 8, 2024
- 4D Molecular Therapeutics Files 8-K — 8-K · Jul 23, 2024
- 4D Molecular Therapeutics Files 8-K Report — 8-K · Jul 17, 2024
- 4D Molecular Therapeutics Files 8-K — 8-K · Jun 7, 2024
- 4D Molecular Therapeutics Holds Annual Stockholder Meeting — 8-K · May 24, 2024
- 4D Molecular Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- 4D Molecular Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 10, 2024
- 4D Molecular Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- 4d Molecular Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- 4D Molecular Therapeutics Files Routine 8-K on Feb 6 Event — 8-K · Feb 9, 2024
- BlackRock Amends 4D Molecular Therapeutics Stake to 7.0% — SC 13G/A · Jan 25, 2024
- Viking Global Amends 4DMT Stake, Signals Continued Interest — SC 13G/A · Jan 8, 2024
- 4D Molecular Therapeutics Reports Officer/Director Changes, Comp. Arrangements — 8-K · Jan 4, 2024